Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 200


National incidence and initial therapy for thymic carcinoma in Japan: based on analysis of hospital-based cancer registry data, 2009-2015.

Koizumi T, Otsuki K, Tanaka Y, Noguchi T, Fukushuima T, Kobayashi T, Ozawa T, Sekiguchi N, Hamanaka K.

Jpn J Clin Oncol. 2020 Mar 5. pii: hyz203. doi: 10.1093/jjco/hyz203. [Epub ahead of print]


Posterior mediastinal ganglioneuroblastoma in an adolescent: A case report and review.

Sekiguchi N, Noguchi T, Fukushima T, Kobayashi T, Ozawa T, Sato Y, Takeda T, Yoshida K, Koizumi T.

Thorac Cancer. 2020 Feb;11(2):451-455. doi: 10.1111/1759-7714.13277. Epub 2019 Dec 14.


Clinical Outcomes of Second-Line Chemotherapy in Patients with Previously Treated Advanced Thymic Carcinoma: A Retrospective Analysis of 191 Patients from the NEJ023 Study.

Tateishi K, Ko R, Shukuya T, Okuma Y, Watanabe S, Kuyama S, Murase K, Tsukita Y, Ashinuma H, Nakagawa T, Uematsu K, Nakao M, Mori Y, Kaira K, Mouri A, Miyabayashi T, Sakashita H, Matsumoto Y, Tanigawa T, Koizumi T, Morita S, Kobayashi K, Nukiwa T, Takahashi K; North East Japan Study Group.

Oncologist. 2019 Nov 26. pii: theoncologist.2019-0593. doi: 10.1634/theoncologist.2019-0593. [Epub ahead of print]


Modified Glasgow Prognostic Score as a Prognostic Factor in Patients with Extensive Disease-Small-Cell Lung Cancer: A Retrospective Study in a Single Institute.

Sonehara K, Tateishi K, Komatsu M, Yamamoto H, Hanaoka M, Kanda S, Koizumi T.

Chemotherapy. 2019;64(3):129-137. doi: 10.1159/000502681. Epub 2019 Oct 17.


In Vivo Administration of Recombinant Human Granulocyte Colony-Stimulating Factor Increases the Immune Effectiveness of Dendritic Cell-Based Cancer Vaccination.

Shimodaira S, Yanagisawa R, Koya T, Hirabayashi K, Higuchi Y, Sakamoto T, Togi M, Kato T Jr, Kobayashi T, Koizumi T, Koido S, Sugiyama H.

Vaccines (Basel). 2019 Sep 19;7(3). pii: E120. doi: 10.3390/vaccines7030120.


Intra-oesophageal invasion of thymoma.

Ozawa M, Fukushima T, Noguchi T, Kobayashi T, Sekiguchi N, Koizumi T.

Respirol Case Rep. 2019 Sep 5;7(8):e00485. doi: 10.1002/rcr2.485. eCollection 2019 Nov.


The efficacy of amrubicin third-line chemotherapy in patients with relapsed extensive-disease small-cell lung cancer: A retrospective and historical study in a single institute.

Sonehara K, Tateishi K, Fukushima T, Komatsu M, Yamamoto H, Koizumi T, Hanaoka M.

Thorac Cancer. 2019 Sep;10(9):1805-1811. doi: 10.1111/1759-7714.13150. Epub 2019 Jul 27.


Late and Rapid Relapse in Mediastinum from Testicular Germ Cell Tumor Stage I Over 13 Years after Surgery.

Fukushima T, Noguchi T, Kobayashi T, Sekiguchi N, Ozawa T, Koizumi T, Tamada H.

Case Rep Oncol. 2019 Jun 26;12(2):500-505. doi: 10.1159/000501446. eCollection 2019 May-Aug.


Twenty-year Follow-up of the First Bilateral Living-donor Lobar Lung Transplantation in Japan.

Komatsu M, Yamamoto H, Shomura T, Sonehara K, Ichiyama T, Urushihata K, Ushiki A, Yasuo M, Wakamatsu T, Sugimoto S, Oto T, Date H, Koizumi T, Hanaoka M, Kubo K.

Intern Med. 2019 Nov 1;58(21):3133-3137. doi: 10.2169/internalmedicine.3160-19. Epub 2019 Jul 10.


Targeted therapy with trastuzumab for epidermal growth factor receptor 2 (HER2)-positive advanced salivary duct carcinoma: A case report.

Gibo T, Sekiguchi N, Gomi D, Noguchi T, Fukushima T, Kobayashi T, Ozawa T, Yamada SI, Koizumi T.

Mol Clin Oncol. 2019 Aug;11(2):111-115. doi: 10.3892/mco.2019.1875. Epub 2019 Jun 10.


[Desensitization Therapy for Osimertinib in Patients Who Developed Toxic Erythema - Two Case Reports].

Watanabe H, Mimura A, Fukushima T, Noguchi T, Ozawa T, Kobayashi T, Sekiguchi N, Ohmori S, Koizumi T.

Gan To Kagaku Ryoho. 2019 May;46(5):961-963. Japanese.


ACTH-producing thymic neuroendocrine tumor initially presenting as psychosis: A case report and literature review.

Okumura T, Takayama S, Nishio SI, Miyakoshi T, Noguchi T, Kobayashi T, Fukushima T, Sekiguchi N, Otsuki T, Komatsu M, Koizumi T.

Thorac Cancer. 2019 Jul;10(7):1648-1653. doi: 10.1111/1759-7714.13099. Epub 2019 Jun 11.


Clinical analysis of EGFR-positive non-small cell lung cancer patients treated with first-line afatinib: A Nagano Lung Cancer Research Group.

Sonehara K, Kobayashi T, Tateishi K, Morozumi N, Yoshiike F, Hachiya T, Ono Y, Takasuna K, Agatsuma T, Masubuchi T, Matsuo A, Tanaka H, Morikawa A, Hanaoka M, Koizumi T.

Thorac Cancer. 2019 May;10(5):1078-1085. doi: 10.1111/1759-7714.13047. Epub 2019 Apr 20.


Plasma cytokine levels and the presence of colorectal cancer.

Yamaguchi M, Okamura S, Yamaji T, Iwasaki M, Tsugane S, Shetty V, Koizumi T.

PLoS One. 2019 Mar 18;14(3):e0213602. doi: 10.1371/journal.pone.0213602. eCollection 2019.


Fluorine-18-fluorodeoxyglucose-positron emission tomography evaluation in metastatic bone lesions in lung cancer: Possible prediction of pain and skeletal-related events.

Gomi D, Fukushima T, Kobayashi T, Sekiguchi N, Koizumi T, Oguchi K.

Thorac Cancer. 2019 Apr;10(4):980-987. doi: 10.1111/1759-7714.13041. Epub 2019 Mar 18.


Solid component tumor doubling time is a prognostic factor in non-small cell lung cancer patients.

Miura K, Hamanaka K, Koizumi T, Kawakami S, Kobayashi N, Ito KI.

J Cardiothorac Surg. 2019 Mar 12;14(1):57. doi: 10.1186/s13019-019-0879-x.


Thymoma-associated graft-versus-host-like disease treated with high-dose i.v. immunoglobulin.

Sato Y, Shirota S, Kiniwa Y, Sekiguchi N, Okuyama R, Koizumi T.

J Dermatol. 2019 Jun;46(6):e224-e225. doi: 10.1111/1346-8138.14757. Epub 2019 Jan 18. No abstract available.


Development of angiosarcoma in a mediastinal non-seminomatous germ cell tumor that exhibited growing teratoma syndrome during chemotherapy.

Matsuoka S, Koyama T, Takeda T, Yamada K, Hyogotani A, Hamanaka K, Sekiguchi N, Koizumi T.

Thorac Cancer. 2019 Jan;10(1):111-115. doi: 10.1111/1759-7714.12901. Epub 2018 Nov 8.


Gastric cancer initially presenting as bone metastasis: Two case reports and a literature review.

Gomi D, Fukushima T, Kobayashi T, Sekiguchi N, Sakamoto A, Mamiya K, Koizumi T.

Oncol Lett. 2018 Nov;16(5):5863-5867. doi: 10.3892/ol.2018.9393. Epub 2018 Sep 4.


Frequent STAT3 mutations in CD8+ T cells from patients with pure red cell aplasia.

Kawakami T, Sekiguchi N, Kobayashi J, Imi T, Matsuda K, Yamane T, Nishina S, Senoo Y, Sakai H, Ito T, Koizumi T, Hirokawa M, Nakao S, Nakazawa H, Ishida F.

Blood Adv. 2018 Oct 23;2(20):2704-2712. doi: 10.1182/bloodadvances.2018022723.

Supplemental Content

Loading ...
Support Center